# Cochrane Risk of Bias 2 (RoB 2) Assessment

## Study & Result Information
- **Study Citation:** Ntritsou V, Vadalouca A, Zis P, Kostopanagiotou G, Siafaka I. Effect of perioperative electroacupuncture as an adjunctive therapy on postoperative analgesia with tramadol and ketamine in prostatectomy: a randomised sham-controlled single-blind trial. *Acupuncture in Medicine*. 2014;32(3):215–222.
- **Source Document in Google Drive:** `covidence_729_full_article.pdf`
- **Trial Registration:** ClinicalTrials.gov NCT01526525
- **Population:** 75 male patients undergoing open radical prostatectomy under general anesthesia.
- **Intervention:** Perioperative EA at bilateral SP6, ST36, LR3, and CV4 initiated 30 min before anesthesia continuing until surgery completion, 2 Hz, current 1–2 mA (n = 37).
- **Comparator:** Sham EA using identical needle insertions at non-acupoints (1.5 cm away) with wires connected to an inactive stimulator delivering 0 mA (n = 38).
- **Assessed Outcome:** Cumulative Postoperative Tramadol Consumption
- **Assessed Timepoint:** 24 hours postoperatively
- **Numerical Result:** 
  - EA group (n = 37): Mean 158.1 ± 28.5 mg
  - Sham EA group (n = 38): Mean 260.5 ± 40.2 mg
  - Difference: Student's t-test, $P < 0.001$ (p. 219 & Table 1)

---

### Step 1: Study Design Verification
- **Experimental Design:** Prospective, randomized, sham-controlled, single-blind parallel trial.
- **Unit of Randomization:** Individual patient.

---

### Step 2: Signaling Questions & Domain Evaluations

#### Domain 1: Risk of bias arising from the randomization process
- **1.1 Random sequence generation:** Yes (Y) — "divided into two groups using a computer-generated random number table" (`covidence_729_full_article.pdf`, p. 216, col. 2).
- **1.2 Allocation concealment:** Yes (Y) — "randomisation was concealed by the director of the clinic who had no clinical involvement in the postoperative analgesia and measurement of pain" (p. 216, col. 2).
- **1.3 Baseline balance:** No (N) — Age (67.4 ± 6.2 vs. 66.8 ± 6.4 yr), BMI, surgical duration, blood loss, and intraoperative ketamine/tramadol doses balanced ($P > 0.05$; Table 1).
- **Domain 1 Judgment:** **Low Risk of Bias**

#### Domain 2: Risk of bias due to deviations from the intended interventions
- **2.1 Participant awareness:** Probably No (PN) — Sham EA applied at non-acupoints with identical visual apparatus; patients informed study evaluated two acupuncture-drug regimens.
- **2.2 Carers awareness:** Probably No (PN) — Postoperative ward nurses administering rescue tramadol/morphine were blinded.
- **2.3 Contextual deviations:** No (N) — Standardized background tramadol+ketamine infusion protocol; standardized rescue criteria (tramadol 50 mg for VAS > 4).
- **2.5 Appropriate analysis:** Yes (Y) — All 75 randomized patients analyzed (37 EA vs. 38 Sham; 100% complete).
- **Domain 2 Judgment:** **Low Risk of Bias**

#### Domain 3: Risk of bias due to missing outcome data
- **3.1 Data completeness:** Yes (Y) — 75 of 75 patients (100%) completed 24-h follow-up.
- **Domain 3 Judgment:** **Low Risk of Bias**

#### Domain 4: Risk of bias in measurement of the outcome
- **4.1 Inappropriate measurement:** No (N) — Validated cumulative infusion and rescue administration charts.
- **4.2 Differ between groups:** No (N)
- **4.3 Assessors aware:** No (N) — "observer-blinded trial... blinded to the study intervention" (p. 216, col. 1).
- **Domain 4 Judgment:** **Low Risk of Bias**

#### Domain 5: Risk of bias in selection of the reported result
- **5.1 Pre-specified analysis plan:** Yes (Y) — Prospectively registered at ClinicalTrials.gov (NCT01526525).
- **5.2 Result selected:** No (N) — Cumulative 24-h tramadol dose systematically reported.
- **5.3 Multiple analyses:** No (N)
- **Domain 5 Judgment:** **Low Risk of Bias**

---

### Step 3: Overall Judgment & Summary Table

| Domain | Judgment | Key Supporting Rationale |
|---|:---:|---|
| **Domain 1: Randomization Process** | **Low** | Computer-generated list; independent clinic director allocation concealment; balanced baseline. |
| **Domain 2: Deviations from Intended Interventions** | **Low** | Participant- and observer-blinded; identical sham needling; 100% complete analysis. |
| **Domain 3: Missing Outcome Data** | **Low** | Zero dropouts (75/75 analyzed). |
| **Domain 4: Measurement of the Outcome** | **Low** | Independent blinded observers recorded analgesic consumption. |
| **Domain 5: Selection of the Reported Result** | **Low** | Prospectively registered at ClinicalTrials.gov (NCT01526525). |
| **OVERALL RISK OF BIAS** | **LOW** | Low risk across all 5 domains. |

---

### Step 4: Evidence Audit
- `covidence_729_full_article.pdf`, p. 216, col. 2: "randomisation was concealed by the director of the clinic who had no clinical involvement".
- `covidence_729_full_article.pdf`, p. 219, col. 1: "24 h tramadol dose in the EA group was 158.1 ± 28.5 mg compared with 260.5 ± 40.2 mg in the control group (p < 0.001)."

---

### Step 5: Author Contact Flags
- None.

---

### Step 6: Final Structured Extraction
```json
{
  "study_id": "Ntritsou_2014",
  "source_file": "covidence_729_full_article.pdf",
  "trial_registration": "NCT01526525",
  "outcome": "Cumulative Postoperative Tramadol Consumption (mg)",
  "timepoint": "24 hours postoperative",
  "sample_size": {"ea": 37, "sham": 38, "total": 75},
  "result": {"ea_mean": 158.1, "ea_sd": 28.5, "sham_mean": 260.5, "sham_sd": 40.2, "p_value": "<0.001"},
  "overall_rob": "Low"
}
```
